USPTO serial 79461977
REPROLIFE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PATEL, SHEENA KAPOOR
- Law office
- TMEG LAW OFFICE 106
What this means
Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.
Need help with REPROLIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Culture media for vitrification of oocytes and/or embryos for medical purposes; culture media for vitrification of living cells for medical purposes; culture media for cryopreservation of oocytes and/or embryos for medical purposes; culture media for cryopreservation of living cells for medical purposes; cell culture media for medical purposes; sperm preparation media; sperm freezing media; culture media for medical purposes; chemical reagents for medical and/or veterinary purposes; pharmaceuticals. | ACTIVE | — |
| 010 | Medical apparatus for vitrification of oocytes and/or embryos; medical apparatus for vitrification of living cells; medical devices for cryopreservation of oocytes and embryos; medical devices for cryopreservation of living cells; in vitro fertilization appliances; catheters; collection needles for oocyte; collection needles for living cells; medical apparatus and instruments. | ACTIVE | — |
| 044 | Medical services relating to the vitrification of oocytes and embryos for artificial insemination; in vitro fertilization services; artificial insemination services; providing information concerning regenerative therapy and/or gene therapy; providing information concerning treatments for cancer and other intractable diseases; medical consulting; preservation of blood; genetic testing for medical purposes; medical laboratory services in the field of hematology; prenatal genetic testing by using blood collected from the mother; providing medical information; medical services relating to cryopreservation of oocytes and embryos for artificial insemination; medical services relating to cryopreservation of sperm for artificial insemination. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 5, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |